Persistent Viral Presence Determines the Clinical Course of the Disease in COVID-19

BACKGROUND: The clinical management of coronavirus disease 2019 (COVID-19) is dependent on understanding the underlying factors that contribute to the disease severity. In the absence of effective antiviral therapies, other host immunomodulatory therapies such as targeting inflammatory response are...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Allergy Clin Immunol Pract
Autors principals: Chang, De, Zhao, Peng, Zhang, Dawei, Dong, Jing-Hui, Xu, Zhe, Yang, Guang, Li, Bo-Yu, Liu, Hong-Xia, Li, Bo-An, Qin, Cheng-Feng, Peng, Xiao-Hua, Wang, Fu-Sheng, Xie, Li-Xin, Chen, Zhu, Dela Cruz, Charles S., Sharma, Lokesh, Qin, En-Qiang
Format: Artigo
Idioma:Inglês
Publicat: American Academy of Allergy, Asthma & Immunology 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305869/
https://ncbi.nlm.nih.gov/pubmed/32574840
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaip.2020.06.015
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars